Interestingly, SIGNR1 blockade failed to improve the survival of infected MPO-deficient mice even at 100-fold lower infection doses, confirming that the beneficial impact of SIGNR1 blockade is mediated by regulating oxidative neutrophil effector function (Supplementary Fig. 5e). Here, MPO is linked to infection.